Dn B Asset Management As Alnylam Pharmaceuticals, Inc. Transaction History

Dn B Asset Management As

$19.9 Billion
Q2 2024

A detailed history of Dn B Asset Management As transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 26,015 shares of ALNY stock, worth $6.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

26,015

Previous 24,993 4.09%

Holding current value

$6.9 Million

Previous $3.74 Million 69.24%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$143.31 - $247.0 $146,462 - $252,434	1,022 Added 4.09%	26,015 $6.32 Million
Q1 2024 Apr 12, 2024	SELL	$146.51 - $198.2 $3.11 Million - $4.21 Million	-21,231 Reduced 45.93%	24,993 $3.74 Million
Q4 2023 Jan 04, 2024	SELL	$151.41 - $196.57 $755,233 - $980,491	-4,988 Reduced 9.74%	46,224 $8.85 Million
Q3 2023 Oct 13, 2023	BUY	$170.77 - $211.65 $4.42 Million - $5.48 Million	25,898 Added 102.31%	51,212 $9.07 Million
Q2 2023 Jul 06, 2023	BUY	$185.01 - $212.05 $369,279 - $423,251	1,996 Added 8.56%	25,314 $4.81 Million
Q1 2023 Apr 20, 2023	BUY	$182.66 - $235.53 $204,761 - $264,029	1,121 Added 5.05%	23,318 $4.67 Million
Q4 2022 Jan 12, 2023	BUY	$185.53 - $241.31 $225,233 - $292,950	1,214 Added 5.79%	22,197 $5.28 Billion
Q3 2022 Oct 11, 2022	SELL	$138.54 - $232.0 $33,803 - $56,608	-244 Reduced 1.15%	20,983 $4.2 Million
Q2 2022 Jul 08, 2022	SELL	$120.42 - $169.29 $15,413 - $21,669	-128 Reduced 0.6%	21,227 $3.1 Billion
Q1 2022 Apr 08, 2022	BUY	$127.18 - $173.91 $237,572 - $324,863	1,868 Added 9.59%	21,355 $3.49 Million
Q4 2021 Jan 12, 2022	BUY	$159.56 - $209.29 $266,465 - $349,514	1,670 Added 9.37%	19,487 $3.3 Million
Q3 2021 Oct 15, 2021	SELL	$169.75 - $207.73 $18,333 - $22,434	-108 Reduced 0.6%	17,817 $3.36 Million
Q2 2021 Jul 06, 2021	SELL	$128.63 - $176.89 $702,448 - $965,996	-5,461 Reduced 23.35%	17,925 $3.04 Billion
Q1 2021 Apr 15, 2021	BUY	$126.83 - $175.69 $967,586 - $1.34 Million	7,629 Added 48.42%	23,386 $3.3 Million
Q4 2020 Jan 19, 2021	BUY	$122.97 - $147.0 $285,536 - $341,334	2,322 Added 17.28%	15,757 $2.05 Million
Q3 2020 Oct 14, 2020	SELL	$121.19 - $165.49 $9,452 - $12,908	-78 Reduced 0.58%	13,435 $1.96 Million
Q2 2020 Jul 08, 2020	BUY	$104.21 - $156.44 $306,168 - $459,620	2,938 Added 27.78%	13,513 $2 Billion
Q1 2020 Apr 17, 2020	SELL	$93.12 - $133.99 $175,903 - $253,107	-1,889 Reduced 15.16%	10,575 $1.15 Million
Q4 2019 Jan 13, 2020	BUY	$74.51 - $124.23 $82,631 - $137,771	1,109 Added 9.77%	12,464 $1.44 Million
Q3 2019 Oct 16, 2019	BUY	$70.9 - $87.82 $805,069 - $997,196	11,355 New	11,355 $913,000
Q1 2019 Apr 11, 2019	SELL	$72.76 - $93.45 $746,590 - $958,890	-10,261 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$62.67 - $88.33 $3,008 - $4,239	48 Added 0.47%	10,261 $748,000
Q3 2018 Oct 10, 2018	BUY	$87.52 - $122.67 $893,841 - $1.25 Million	10,213 New	10,213 $0

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Alnylam Pharmaceuticals, Inc. Transaction History